Documents to download

Uses of data within the NHS include improving decision-making in patient care and monitoring both the success of treatments and the performance of care providers. Outside the NHS, data is sought by, for example, academics for research and commercial organisations for monitoring and developing drugs. The Medical Research Council has stated that the UK could be a global leader in the field of health data research. However, there are also challenges in using healthcare data. Some of these are technological, but there is also widespread concern about privacy and public trust, partly in the light of recent breaches of data security.

The use of data in healthcare in England is guided and delivered by a range of organisations. The roles of these bodies have sometimes overlapped, and some past strategies for data usage are no longer considered appropriate. Steps are currently being taken to address these issues. The recently appointed Secretary of State for Health and Social Care, Matt Hancock, has also stated that technology was one of his three “early priorities” and committed £475 million to enhance technology-driven health and care.

Two emerging data-driven technologies with the potential to improve healthcare outcomes are artificial intelligence and genomics. These also highlight the potential commercial value of NHS data and there are debates about how this might be realised. Data and technology might also be used to reduce costs in the NHS, with one estimate putting potential savings at 7 to 11.5 percent of healthcare expenditure.


Documents to download

Related posts

  • Public health information has been a central tool in the Government’s fight against Covid-19. However, the public’s ability to obtain, process and understand health information is variable, with 61% of adults in one observational study struggling to understand health information that included both text and numbers. This article examines some of the barriers to understanding public health information, particularly in the context of the Covid-19 pandemic. It also looks at what the Government is doing to improve levels of health literacy.

  • The draft Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 and the draft Medical Devices (Amendment etc.) (EU Exit) Regulations 2020 seek to amend how clinical trials, medicines and medical devices will be regulated in both Great Britain and Northern Ireland after 31 December 2020, whilst taking into account the Northern Ireland Protocol. Under the Protocol, trade in goods between Northern Ireland and Ireland, and between Northern Ireland and EU Member States, will continue unaffected.

  • The Government has announced that the England-wide Covid-19 restrictions commonly referred to as ‘lockdown 2’ will not be renewed past 2 December 2020. The restrictions are to be replaced with a revised tier structure for England similar to the one in place before the second lockdown. The revised tiers form part of the Government’s Winter Plan, which was announced on 23 November 2020.